NuGen Medical Devices Inc V.NGMD

Alternate Symbol(s): NGMDF

NuGen Medical Devices Inc. is a Canada-based specialty medical device company. The Company is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. It is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. It is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The Company's InsuJet technology platform is based on jet-stream administration of liquid drugs. The Company manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.

TSXV:NGMD - Post by User

NuGen Medical Devices Inc > New Press Release - NuGen Medical Commences Feasibility Study, Validation and Testing for Semaglutide - "Ozempic(R)"

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Oct 10, 2023 1:53pm

59 Views

Post# 35677376

RE:New Press Release - NuGen Medical Commences Feasibility Study, Validation and Testing for Semaglutide - "Ozempic(R)"

The 4 to 5 months time frame is up. News soon?

Conclusion of Phase 3, estimated at four-to-five-months, will determine a Go/No-Go outcome which will be reported to shareholders.

<< Previous

Bullboard Posts

Next >>

This AI stock is disrupting the event tickets monopoly